Ultrasonic gene and drug delivery to the cardiovascular system.
about
Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery.Targeted microbubbles: a novel application for the treatment of kidney stones.The partitioning of nanoparticles to endothelium or interstitium during ultrasound-microbubble-targeted delivery depends on peak-negative pressure.Optical Verification of Microbubble Response to Acoustic Radiation Force in Large Vessels With In Vivo ResultsUltrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study.Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.Binding dynamics of targeted microbubbles in response to modulated acoustic radiation forceCalibration of the 1-MHz Sonitron ultrasound system.Real-time technique for improving molecular imaging and guiding drug delivery in large blood vessels: in vitro and ex vivo resultsTargeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery.Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers.Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubblesBreakup of finite thickness viscous shell microbubbles by ultrasound: a simplified zero-thickness shell model.Emerging diagnostic and therapeutic molecular imaging applications in vascular diseaseContrast imaging and gene delivery through the combined use of novel cationic liposomal microbubbles and ultrasound in rat carotid arteries.Production of uniformly sized serum albumin and dextrose microbubbles.Contrast agent-free sonoporation: The use of an ultrasonic standing wave microfluidic system for the delivery of pharmaceutical agents.Over-pressure suppresses ultrasonic-induced drug uptakeThree-dimensional modeling of the dynamics of therapeutic ultrasound contrast agents.Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles.Protein expression of mesenchymal stem cells after transfection of pcDNA3.1⁻-hVEGF₁₆₅ by ultrasound-targeted microbubble destruction.Cellular Injury of Cardiomyocytes during Hepatocyte Growth Factor Gene Transfection with Ultrasound-Triggered Bubble Liposome DestructionUltrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles.βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failureProtein kinase C in heart failure: a therapeutic target?Gene and cell therapy for heart failure.Sonophoresis: recent advancements and future trends.Ultrasound-mediated gene delivery.EGFP gene transfection into the synovial joint tissues of rats with rheumatoid arthritis by ultrasound-mediated microbubble destruction.Adjuvant early and late cardioprotective therapy: access to the heart.Gene delivery nanoparticles to modulate angiogenesis.Microbubble-sonosensitiser conjugates as therapeutics in sonodynamic therapy.A novel dual-targeted ultrasound contrast agent provides improvement of gene delivery efficiency in vitro.Ultrasound-induced microbubble destruction promotes targeted delivery of adipose-derived stem cells to improve hind-limb ischemia of diabetic mice.Ultrasound-triggered microbubble destruction in combination with cationic lipid microbubbles enhances gene delivery.
P2860
Q26859479-D0FBDBC1-5390-47B7-AF9B-DAFB4EE35C39Q27030812-2B1B5A13-7BB8-43A4-8FAD-7F64C47BA564Q30278047-C0D38230-90D2-4542-BDB9-DF92F9DB3E00Q30279077-9297DFCD-77EF-4914-B84B-96EE170B9BF0Q30303105-28F1BB16-8B47-4DB0-AC62-61F4B176E49FQ30367062-096FD0CA-F237-45CA-9568-10C840C5F2DCQ30376391-887E6673-52F4-4CE7-8900-06519FADA394Q30408549-01C38437-E61C-415B-A2B7-C7EF91E943B0Q30416852-58400F72-1354-42C2-B1B0-824B4ED0546DQ30430526-EEA05421-D58E-4C57-8043-631E2000A27CQ30430948-DB98BB16-2379-4AB2-9D99-7E37E1851040Q30432005-F911F658-0E5F-46DB-853F-F77E8E696F3CQ30432859-C66180BE-8BFE-4FFF-840F-22E5F09D6DF8Q30433160-BC45B08A-D0B2-4500-AC08-1E870AAB2088Q30450437-61D65176-4AF7-499C-A1F1-34DD1AF58253Q30454668-BEC9C2DF-5CC1-44EF-B9D6-C88DC3C6F9C8Q30459677-B75816B5-DB68-4AD1-AB70-536F831B351BQ30466956-5EDE3C6A-17FD-48DA-A91F-2410E9A57DA2Q30469311-2CAE361D-5D2F-48E7-96F7-232B9D40FE99Q30472683-4152EBA2-E4EB-455C-86D6-FEC7A11F8AB3Q30473728-94C7E60E-FF09-4A05-8E2D-A3520CE1917EQ30475028-71BAB77B-1EC3-4B96-B4ED-F68BF3730935Q30475761-FD2508A7-EC3B-495E-A476-9DCC9A2FDC60Q30491066-415BDDE3-A843-4CF1-9FE7-3A5CF9E0F748Q35103455-6548832C-2A73-4927-B415-E1E51101707AQ37176180-A8764269-D078-4676-A17A-52DA0B32C130Q37470623-CC2EECE8-694A-4748-A63C-6C648EBF4B4AQ37511028-5F919BF7-A959-465F-84A3-1F20046A2B9CQ37694573-71CC943A-3310-4886-824D-819678072779Q37710028-D93F6587-CC41-4354-994F-BC43B01C133BQ37982681-4394A570-880D-4566-AEA5-F4BC34EC3058Q39027588-FBE02DB3-D9C3-462C-AA1C-2596B042B5C5Q39315624-42F5C79B-F6FE-4489-B07C-173D1731C1D1Q39608614-05C73567-2F12-4D70-959B-AF6508D792BCQ42068597-AC24C3A2-AA2A-403E-8268-D5A1D78FF5BCQ50526391-D4122313-9B72-4D99-898A-8E5352753459
P2860
Ultrasonic gene and drug delivery to the cardiovascular system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ultrasonic gene and drug delivery to the cardiovascular system.
@en
Ultrasonic gene and drug delivery to the cardiovascular system.
@nl
type
label
Ultrasonic gene and drug delivery to the cardiovascular system.
@en
Ultrasonic gene and drug delivery to the cardiovascular system.
@nl
prefLabel
Ultrasonic gene and drug delivery to the cardiovascular system.
@en
Ultrasonic gene and drug delivery to the cardiovascular system.
@nl
P1476
Ultrasonic gene and drug delivery to the cardiovascular system.
@en
P2093
Christian R Mayer
Raffi Bekeredjian
P304
P356
10.1016/J.ADDR.2008.03.004
P407
P577
2008-04-03T00:00:00Z